nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—NFATC1—periosteum—cleft lip	0.16	0.613	CbGeAlD
Pseudoephedrine—NFATC1—head—cleft lip	0.0165	0.0629	CbGeAlD
Pseudoephedrine—IL2—head—cleft lip	0.015	0.0575	CbGeAlD
Pseudoephedrine—SLC6A3—telencephalon—cleft lip	0.00639	0.0244	CbGeAlD
Pseudoephedrine—ADRB1—telencephalon—cleft lip	0.00606	0.0232	CbGeAlD
Pseudoephedrine—SLC6A4—telencephalon—cleft lip	0.00585	0.0224	CbGeAlD
Pseudoephedrine—MAOA—embryo—cleft lip	0.00584	0.0223	CbGeAlD
Pseudoephedrine—SLC6A2—telencephalon—cleft lip	0.00515	0.0197	CbGeAlD
Pseudoephedrine—ADRA1A—telencephalon—cleft lip	0.00479	0.0183	CbGeAlD
Pseudoephedrine—MAOA—telencephalon—cleft lip	0.00475	0.0181	CbGeAlD
Pseudoephedrine—SLC6A3—head—cleft lip	0.00398	0.0152	CbGeAlD
Pseudoephedrine—ADRB1—head—cleft lip	0.00377	0.0144	CbGeAlD
Pseudoephedrine—SLC6A4—head—cleft lip	0.00364	0.0139	CbGeAlD
Pseudoephedrine—ADRA2A—telencephalon—cleft lip	0.00364	0.0139	CbGeAlD
Pseudoephedrine—SLC6A2—head—cleft lip	0.00321	0.0123	CbGeAlD
Pseudoephedrine—ADRA1A—head—cleft lip	0.00298	0.0114	CbGeAlD
Pseudoephedrine—MAOA—head—cleft lip	0.00296	0.0113	CbGeAlD
Pseudoephedrine—CYP2D6—telencephalon—cleft lip	0.00282	0.0108	CbGeAlD
Pseudoephedrine—TNF—Vitamin B12 Metabolism—MTHFR—cleft lip	0.00254	0.00344	CbGpPWpGaD
Pseudoephedrine—IL2—Regulation of Telomerase—MYC—cleft lip	0.00251	0.00339	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—WNT9B—cleft lip	0.00249	0.00337	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—WNT9B—cleft lip	0.00248	0.00336	CbGpPWpGaD
Pseudoephedrine—TNF—Cardiac Hypertrophic Response—FGFR2—cleft lip	0.00248	0.00336	CbGpPWpGaD
Pseudoephedrine—SLC6A4—NRF2 pathway—TGFA—cleft lip	0.00247	0.00334	CbGpPWpGaD
Pseudoephedrine—IL2—AP-1 transcription factor network—MYC—cleft lip	0.00245	0.00332	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—FGF7—cleft lip	0.00243	0.00329	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	0.00238	0.00322	CbGpPWpGaD
Pseudoephedrine—ADRA2A—head—cleft lip	0.00227	0.00867	CbGeAlD
Pseudoephedrine—NFATC1—Immune System—IRF6—cleft lip	0.00226	0.00305	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—BMP4—cleft lip	0.00224	0.00304	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—FGF8—cleft lip	0.00224	0.00303	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—ABCA4—cleft lip	0.00221	0.003	CbGpPWpGaD
Pseudoephedrine—SLC6A2—NRF2 pathway—TGFA—cleft lip	0.00212	0.00287	CbGpPWpGaD
Pseudoephedrine—ADRB1—Endothelin Pathways—NOS3—cleft lip	0.00212	0.00286	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—FGF2—cleft lip	0.00211	0.00285	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—MTHFR—cleft lip	0.00207	0.0028	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—SLC19A1—cleft lip	0.00203	0.00274	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—WNT3—cleft lip	0.00198	0.00268	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—WNT3—cleft lip	0.00197	0.00267	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IRF6—cleft lip	0.00191	0.00258	CbGpPWpGaD
Pseudoephedrine—SLC6A3—NRF2 pathway—TGFA—cleft lip	0.00188	0.00255	CbGpPWpGaD
Pseudoephedrine—TNF—Angiopoietin receptor Tie2-mediated signaling—FGF2—cleft lip	0.00182	0.00247	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—FGF3—cleft lip	0.00182	0.00247	CbGpPWpGaD
Pseudoephedrine—TNF—Angiopoietin receptor Tie2-mediated signaling—NOS3—cleft lip	0.0018	0.00244	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—FGF9—cleft lip	0.00178	0.00241	CbGpPWpGaD
Pseudoephedrine—TNF—MicroRNAs in cardiomyocyte hypertrophy—FGFR2—cleft lip	0.00177	0.0024	CbGpPWpGaD
Pseudoephedrine—CYP2D6—head—cleft lip	0.00176	0.00672	CbGeAlD
Pseudoephedrine—NFATC1—Signaling Pathways—WNT9B—cleft lip	0.00174	0.00236	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—EPHA3—cleft lip	0.00173	0.00234	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Endothelin Pathways—NOS3—cleft lip	0.00171	0.00232	CbGpPWpGaD
Pseudoephedrine—MAOA—Biological oxidations—MTR—cleft lip	0.0017	0.0023	CbGpPWpGaD
Pseudoephedrine—TNF—Cardiac Hypertrophic Response—FGF2—cleft lip	0.00169	0.00229	CbGpPWpGaD
Pseudoephedrine—NFATC1—Ectoderm Differentiation—MYC—cleft lip	0.00168	0.00228	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—TCN2—cleft lip	0.00168	0.00227	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NOG—cleft lip	0.00167	0.00226	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—TGFB3—cleft lip	0.00166	0.00225	CbGpPWpGaD
Pseudoephedrine—TNF—Selenium Micronutrient Network—MTHFR—cleft lip	0.00164	0.00222	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—MYC—cleft lip	0.00161	0.00218	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ABCA4—cleft lip	0.00155	0.0021	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—SUMO1—cleft lip	0.00155	0.00209	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—WNT9B—cleft lip	0.00152	0.00206	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—FGF10—cleft lip	0.0015	0.00203	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—WNT9B—cleft lip	0.00149	0.00202	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—WNT9B—cleft lip	0.00147	0.00199	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—MYC—cleft lip	0.00144	0.00195	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—FGF7—cleft lip	0.00141	0.00191	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NOG—cleft lip	0.00141	0.00191	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—WNT3—cleft lip	0.00138	0.00187	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ABCA4—cleft lip	0.00131	0.00178	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—SUMO1—cleft lip	0.00131	0.00177	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—FGF7—cleft lip	0.00131	0.00177	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—SPRY2—cleft lip	0.00131	0.00177	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—FGF8—cleft lip	0.0013	0.00177	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor—MYC—cleft lip	0.00127	0.00173	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00124	0.00168	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—WNT9B—cleft lip	0.00123	0.00167	CbGpPWpGaD
Pseudoephedrine—TNF—Ceramide signaling pathway—MYC—cleft lip	0.00123	0.00167	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—WNT3—cleft lip	0.00121	0.00164	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—FGF8—cleft lip	0.0012	0.00163	CbGpPWpGaD
Pseudoephedrine—TNF—MicroRNAs in cardiomyocyte hypertrophy—FGF2—cleft lip	0.0012	0.00163	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—FGFR2—cleft lip	0.0012	0.00163	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—FGF7—cleft lip	0.0012	0.00162	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—WNT3—cleft lip	0.00118	0.0016	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—WNT3—cleft lip	0.00117	0.00158	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—MTR—cleft lip	0.00116	0.00158	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—WNT9B—cleft lip	0.00115	0.00155	CbGpPWpGaD
Pseudoephedrine—NFATC1—RNF mutants show enhanced WNT signaling and proliferation—MYC—cleft lip	0.00113	0.00153	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TYMS—cleft lip	0.00112	0.00152	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—FGFR1—cleft lip	0.00112	0.00152	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—NODAL—cleft lip	0.00111	0.00151	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—FGF8—cleft lip	0.0011	0.00149	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—ABCA4—cleft lip	0.0011	0.00149	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—PTCH1—cleft lip	0.00108	0.00147	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—FGF3—cleft lip	0.00106	0.00144	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—FGFR3—cleft lip	0.00106	0.00144	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling by WNT in cancer—MYC—cleft lip	0.00105	0.00142	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—FGF9—cleft lip	0.00104	0.0014	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.00101	0.00137	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—FGF3—cleft lip	0.00098	0.00133	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—WNT3—cleft lip	0.000979	0.00133	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—FGF9—cleft lip	0.000956	0.00129	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—FGFR1—cleft lip	0.000947	0.00128	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—FGF7—cleft lip	0.000914	0.00124	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—SPRY2—cleft lip	0.000914	0.00124	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—WNT3—cleft lip	0.00091	0.00123	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—FGF3—cleft lip	0.000898	0.00122	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—FGF9—cleft lip	0.000876	0.00119	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—FGF10—cleft lip	0.000873	0.00118	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling by Wnt—MYC—cleft lip	0.000865	0.00117	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TGFB3—cleft lip	0.000858	0.00116	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.000855	0.00116	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—FGF8—cleft lip	0.000843	0.00114	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ARHGAP29—cleft lip	0.000843	0.00114	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ARHGAP29—cleft lip	0.000824	0.00112	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—FGF2—cleft lip	0.000819	0.00111	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—FGF10—cleft lip	0.000806	0.00109	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—MYC—cleft lip	0.000787	0.00107	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—WNT9B—cleft lip	0.000782	0.00106	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—FGF7—cleft lip	0.000773	0.00105	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SPRY2—cleft lip	0.000773	0.00105	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—WNT9B—cleft lip	0.000765	0.00104	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—NOS3—cleft lip	0.000759	0.00103	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—PTCH1—cleft lip	0.000757	0.00103	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—MTR—cleft lip	0.000741	0.001	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—FGF10—cleft lip	0.000739	0.001	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—FGF8—cleft lip	0.000713	0.000966	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—FGFR2—cleft lip	0.000701	0.000949	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—FGF3—cleft lip	0.000687	0.00093	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ARHGAP29—cleft lip	0.000682	0.000923	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—FGF9—cleft lip	0.000669	0.000907	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—PTCH1—cleft lip	0.000663	0.000898	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—FGFR1—cleft lip	0.000653	0.000885	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—PTCH1—cleft lip	0.000649	0.000878	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—FGFR2—cleft lip	0.000647	0.000876	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PTCH1—cleft lip	0.000641	0.000867	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ARHGAP29—cleft lip	0.000634	0.000858	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—WNT9B—cleft lip	0.000632	0.000856	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000624	0.000845	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—MTHFR—cleft lip	0.000623	0.000843	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—WNT3—cleft lip	0.000621	0.000841	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—FGFR3—cleft lip	0.000617	0.000836	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—WNT3—cleft lip	0.000607	0.000823	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—FGFR1—cleft lip	0.000603	0.000817	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—MYC—cleft lip	0.0006	0.000812	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—FGFR2—cleft lip	0.000593	0.000803	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—WNT9B—cleft lip	0.000588	0.000796	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—FGF3—cleft lip	0.000581	0.000786	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—FGFR3—cleft lip	0.00057	0.000772	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—FGF9—cleft lip	0.000566	0.000767	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—FGF10—cleft lip	0.000565	0.000765	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—FGFR1—cleft lip	0.000552	0.000748	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—PTCH1—cleft lip	0.000536	0.000726	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—FGF10—cleft lip	0.000534	0.000724	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—FGFR3—cleft lip	0.000522	0.000707	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—SLC19A1—cleft lip	0.000507	0.000686	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—WNT3—cleft lip	0.000502	0.00068	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—PTCH1—cleft lip	0.000498	0.000675	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—FGF10—cleft lip	0.000478	0.000647	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—FGF2—cleft lip	0.000477	0.000646	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—WNT3—cleft lip	0.000467	0.000632	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—WNT9B—cleft lip	0.000462	0.000625	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—FGFR2—cleft lip	0.000453	0.000614	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—MYC—cleft lip	0.000452	0.000612	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—WNT9B—cleft lip	0.000452	0.000612	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOG—cleft lip	0.000443	0.000599	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—FGF2—cleft lip	0.00044	0.000597	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—NOS3—cleft lip	0.000434	0.000588	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOG—cleft lip	0.000433	0.000586	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—FGFR1—cleft lip	0.000422	0.000572	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TCN2—cleft lip	0.00042	0.000568	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ABCA4—cleft lip	0.000412	0.000557	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000408	0.000553	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—FGF2—cleft lip	0.000404	0.000546	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ABCA4—cleft lip	0.000403	0.000545	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—FGFR1—cleft lip	0.0004	0.000541	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—FGFR3—cleft lip	0.000399	0.000541	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—FGFR2—cleft lip	0.000383	0.000519	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—WNT9B—cleft lip	0.000374	0.000506	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—WNT3—cleft lip	0.000367	0.000497	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—WNT3—cleft lip	0.000359	0.000486	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOG—cleft lip	0.000358	0.000485	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—FGFR1—cleft lip	0.000357	0.000484	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—WNT9B—cleft lip	0.000347	0.00047	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PTCH1—cleft lip	0.00034	0.000461	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SLC19A1—cleft lip	0.000338	0.000458	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—FGFR3—cleft lip	0.000338	0.000457	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ABCA4—cleft lip	0.000333	0.000451	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PTCH1—cleft lip	0.000333	0.000451	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOG—cleft lip	0.000333	0.000451	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ABCA4—cleft lip	0.000309	0.000419	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—FGF2—cleft lip	0.000308	0.000418	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NOS3—cleft lip	0.000304	0.000412	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—WNT3—cleft lip	0.000297	0.000402	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—FGF2—cleft lip	0.000292	0.000395	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—MTR—cleft lip	0.000291	0.000394	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—MYC—cleft lip	0.000288	0.00039	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TCN2—cleft lip	0.00028	0.00038	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—WNT3—cleft lip	0.000276	0.000373	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PTCH1—cleft lip	0.000275	0.000373	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—FGF2—cleft lip	0.000261	0.000353	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NOS3—cleft lip	0.000257	0.000348	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PTCH1—cleft lip	0.000256	0.000346	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SPRY2—cleft lip	0.000243	0.000328	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGF7—cleft lip	0.000243	0.000328	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGF7—cleft lip	0.000237	0.000321	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SPRY2—cleft lip	0.000237	0.000321	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGF8—cleft lip	0.000224	0.000303	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC19A1—cleft lip	0.000221	0.000299	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGF8—cleft lip	0.000219	0.000297	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MYC—cleft lip	0.000202	0.000273	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTCH1—cleft lip	0.000201	0.000272	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTCH1—cleft lip	0.000197	0.000266	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SPRY2—cleft lip	0.000196	0.000266	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGF7—cleft lip	0.000196	0.000266	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—MTR—cleft lip	0.000194	0.000263	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TCN2—cleft lip	0.000183	0.000247	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SPRY2—cleft lip	0.000182	0.000247	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGF7—cleft lip	0.000182	0.000247	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGF3—cleft lip	0.000182	0.000247	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGF8—cleft lip	0.000181	0.000245	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—NOS3—cleft lip	0.000179	0.000242	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TYMS—cleft lip	0.000178	0.000241	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGF3—cleft lip	0.000178	0.000241	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGF9—cleft lip	0.000178	0.000241	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGF9—cleft lip	0.000174	0.000235	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MYC—cleft lip	0.000171	0.000231	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGF8—cleft lip	0.000168	0.000228	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTCH1—cleft lip	0.000163	0.00022	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—MTHFR—cleft lip	0.000156	0.000211	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTCH1—cleft lip	0.000151	0.000205	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGF10—cleft lip	0.00015	0.000203	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGF3—cleft lip	0.000147	0.0002	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGF10—cleft lip	0.000147	0.000199	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGF9—cleft lip	0.000144	0.000195	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGF3—cleft lip	0.000137	0.000186	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGF9—cleft lip	0.000134	0.000181	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MTR—cleft lip	0.000127	0.000172	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGF10—cleft lip	0.000121	0.000164	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGFR2—cleft lip	0.00012	0.000163	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TYMS—cleft lip	0.000119	0.000161	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGFR2—cleft lip	0.000118	0.000159	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGF10—cleft lip	0.000113	0.000153	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGFR1—cleft lip	0.000112	0.000152	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGFR1—cleft lip	0.00011	0.000148	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—NOS3—cleft lip	0.000109	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGFR3—cleft lip	0.000106	0.000143	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—MTHFR—cleft lip	0.000104	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGFR3—cleft lip	0.000104	0.00014	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGFR2—cleft lip	9.73e-05	0.000132	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGFR1—cleft lip	9.07e-05	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGFR2—cleft lip	9.04e-05	0.000122	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGFR3—cleft lip	8.57e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGFR1—cleft lip	8.43e-05	0.000114	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGF2—cleft lip	8.19e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOS3—cleft lip	8.07e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGF2—cleft lip	8.01e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGFR3—cleft lip	7.96e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOS3—cleft lip	7.9e-05	0.000107	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TYMS—cleft lip	7.76e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NOS3—cleft lip	7.26e-05	9.83e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MTHFR—cleft lip	6.78e-05	9.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGF2—cleft lip	6.62e-05	8.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOS3—cleft lip	6.53e-05	8.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGF2—cleft lip	6.15e-05	8.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOS3—cleft lip	6.07e-05	8.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MYC—cleft lip	5.35e-05	7.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MYC—cleft lip	5.24e-05	7.09e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NOS3—cleft lip	4.73e-05	6.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MYC—cleft lip	4.33e-05	5.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MYC—cleft lip	4.02e-05	5.45e-05	CbGpPWpGaD
